February 27, 2020

Transplant Diagnostics Market Is Expected To Reach US$ 1,167.4 Mn By 2026 | Credence Research

The latest market report published by Credence Research, Inc. “Transplant Diagnostics Market – Growth, Future Prospects, Competitive Analysis, 2018 – 2026,” the global market for transplant diagnostics was estimated at US$ 609.1 million in 2017, growing at CAGR by 7.4 per cent from 2018 to 2026, to reach US$ 1.167.4 by 2026.

Market Insights

Antibody-mediated organ allograft rejection is a difficult complication to treat due to allo-transplantation. Evolution in diagnostic methods has made it possible to better detect and identify antibodies specific to organ acceptance and rejection. In addition, studies are being conducted to examine the frequency of non-HLA specific antibodies in graft recipients after transplantation as well as during transplantation. The evolution of diagnostic tests improved the clinical outcomes of organ transplantation. The risk of organ rejection can be significantly reduced by the precise matching of the donor and the compatibility of the donor. Conventional techniques such as human leukocyte antigen (HLA) are used worldwide. However, the use of molecular assay methods such as PCR and sequencing has been shown to be efficient and increasing demand in global markets.

Browse Full Report Originally Published by Credence Research at https://www.credenceresearch.com/report/transplant-diagnostics-market

Increasing numbers of transplantation procedures are expected to increase the demand for transplantation diagnostics. International health organizations such as the WHO have developed health care plans and agendas to increase awareness of the uptake of organs and stem cell transplantation. For example, the Organ Harvesting Initiative launched by the European Commission has resulted in increased availability of organs for transplantation in the region and also increased general awareness.

The global market for transplant diagnostics is generally classified on the basis of technologies, applications, type of transplant, products, areas of use and geographical demarcation. Non-molecular assays currently dominate the global market for transplant diagnostics. Swift progress in the field of end-stage organ failure and transplant medicine and the increasing adoption of immunomodulatory treatments has increased the demand for transplant diagnostic methods in global markets.

The global market dominated the segment of reagents and consumables of product types in 2017 and will continue to lead over the forecast period. Repeat purchase volume is the key factor to support the dominance of this segment. Hospitals and diagnostic laboratories are required to enter into long-term contracts with suppliers to ensure the safety of price variations and to ensure the continued supply of frequently needed products. On the basis of applications, pre-and post-transplant diagnostics are the world’s leading contributors.

Solid organ transplantation is a key area in which transplantation diagnostic methods are widely used. The sheer volume of transplantation procedures in the heart, lungs, liver, pancreas, and kidneys is a driving factor in the dominance of this segment. On the other hand, increasing developments in the field of stem cell transplantation and its increasing application in a number of disease areas will bring rapid market growth to this segment. Hospitals and transplant centers will have the largest market share in the forecast period, due to increased patient footfall and high post-transplant follow-up volumes.

North America is a clear leader in the global market for transplant diagnostics. The key factors that characterize the North American market are the favorable regulatory scenario, increased awareness and a significant pool of patients with chronic diseases at high risk of organ failure. Asia Pacific will see rapid market growth and cannibalize North America’s market share between 2018 and 2026. Improving awareness, increasing population incomes, developing healthcare professionals ‘ skills and providing government support are the primary drivers for the growth of the Asia-Pacific market. The global market for transplant diagnostics is highly competitive with a limited number of business players. Product differentiation in this sector is limited but differentiated, thus enhancing overall competition among market players.

Key Major Players: Thermo Fisher Scientific, Inc., Abbott Laboratories, Inc., Bio-Rad Laboratories, Bio-Reference Laboratories, F. Hoffmann-La Roche Ltd., Immucor, Inc., Illumina, Inc., Qiagen N.V., Luminex Corporation, and Genome Diagnostics B.V.

Key Market Movements:

  • Significant growth in global geriatric population, along with growing risk of organ failure
  • High incidence of organ failure in developed markets of North America and Europe
  • Increasing awareness supported by health organizations and governments promoting the uptake of transplantation procedures
  • Limited organ donors challenging the market growth

Access Free Sample Copy of Research Report: https://www.credenceresearch.com/sample-request/58046

[Note: Our Free Complimentary Sample Report Accommodate a Brief Introduction To The Synopsis, TOC, List of Tables and Figures, Competitive Landscape and Geographic Segmentation, Innovation and Future Developments Based on Research Methodology are also Included]

Report Scope by Segments

By Technology Type

  • Molecular Assays
    • PCR Based Molecular Assays
    • Sequencing Based Molecular Assays
      • Sanger Sequencing
      • Next Generation Sequencing 
  • Non-molecular Assays
    • Serological Assays
    • Mixed Lymphocyte Culture (MLC) Testing

By Transplant Type

  • Solid Organ Transplantation
  • Stem Cell Transplantation

By Application Type

  • Pre-transplantation Diagnostics
  • Post-transplantation Diagnostics
  • Research

By Products Type

  • Instruments
  • Reagents and Consumables
  • Software

By Usage Area Type

  • Hospitals and Transplant Centers
  • Research and Academia
  • Pathophysiology Laboratories

By Geography Segment

  • North America (U.S., Rest of North America)
  • Europe (U.K., Germany, France, Rest of Europe)
  • Asia Pacific (China, Japan, India, Rest of Asia Pacific)
  • Rest of the World (Middle East & Africa, Latin America)

Key questions answered in this report

  • What is the current position of the global transplant diagnostics market in the base year 2017?
  • How will the market progress through the forecast period from 2018 to 2026 to the forecasted market size?
  • Which are the prime diagnostic technologies occupying dominance in the global transplant diagnostics market?
  • Which transplant type holds the lead position in terms of market size?
  • Why hospitals and transplant centers are the key revenue-generating segment in the global transplant diagnostics market and how pathophysiology centers segment is challenging its position?
  • Will Asia Pacific surpass the lead of North America and Europe during the forecast period?
  • What are the key market movements observed from the strategies adopted by the major market players?

Access Free Sample Copy of Research Report: https://www.credenceresearch.com/sample-request/58046

Leave a Reply

Your email address will not be published. Required fields are marked *